82 results on '"Takehara, Kazuhiko"'
Search Results
2. Safety and tolerability of bosentan for digital ulcers in Japanese patients with systemic sclerosis: Prospective, multicenter, open‐label study
3. Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity
4. Clinical and Immunologic Predictors of Scleroderma Renal Crisis in Japanese Systemic Sclerosis Patients With Anti–RNA Polymerase III Autoantibodies
5. Proteomic identification of heterogeneous nuclear ribonucleoprotein K as a novel cold-associated autoantigen in patients with secondary Raynaud’s phenomenon
6. A Crucial Role of L-Selectin in C Protein–Induced Experimental Polymyositis in Mice
7. FTY720 Ameliorates Murine Sclerodermatous Chronic Graft-Versus-Host Disease by Promoting Expansion of Splenic Regulatory Cells and Inhibiting Immune Cell Infiltration Into Skin
8. Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis
9. Anti-topoisomerase I antibody levels as serum markers of skin sclerosis in systemic sclerosis
10. PLD4 as a novel susceptibility gene for systemic sclerosis in a Japanese population
11. Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort
12. Two cases of livedo vasculopathy with non-criteria antiphospholipid antibodies
13. Skin sclerosis as a manifestation of POEMS syndrome
14. Potential roles of interleukin-17A in the development of skin fibrosis in mice
15. Association of UBE2L3 polymorphisms with diffuse cutaneous systemic sclerosis in a Japanese population
16. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy
17. Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins
18. Investigation of prognostic factors for skin sclerosis and lung function in Japanese patients with early systemic sclerosis: a multicentre prospective observational study
19. Association between nail-fold capillary findings and disease activity in dermatomyositis
20. Clinical Correlations With Dermatomyositis-Specific Autoantibodies in Adult Japanese Patients With Dermatomyositis: A Multicenter Cross-sectional Study
21. Mobilization of endothelial progenitor cells by intravenous cyclophosphamide in patients with systemic sclerosis
22. Usefulness of anti-cyclic citrullinated peptide antibody and rheumatoid factor to detect rheumatoid arthritis in patients with systemic sclerosis
23. Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis: 90074
24. Inducible costimulator ligand regulates bleomycin-induced lung and skin fibrosis in a mouse model independently of the inducible costimulator/inducible costimulator ligand pathway
25. Intractable genital ulcers from herpes simplex virus reactivation in drug-induced hypersensitivity syndrome caused by allopurinol
26. Association of the FAM167A–BLK region with systemic sclerosis
27. Re-emergence of anti-topoisomerase I antibody with exacerbated development of skin sclerosis in a patient with systemic sclerosis
28. Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase A, in systemic sclerosis: association with pulmonary fibrosis and vascular damage
29. Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay
30. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis
31. Esophageal transit scintigraphy and structured questionnaire in patients with systemic sclerosis with endoscopically proven reflux esophagitis
32. Guidelines for management of atopic dermatitis
33. Reduced red blood cell velocity in nail-fold capillaries as a sensitive and specific indicator of microcirculation injury in systemic sclerosis
34. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population
35. Bullous pemphigoid with a prolonged prodrome
36. Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis
37. Antiphospholipid antibodies in patients with autoimmune blistering disease
38. Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients
39. Elevated serum BAFF levels in patients with localized scleroderma in contrast to other organ-specific autoimmune diseases
40. Elevated Human Tissue Kallikrein Levels in the Stratum Corneum and Serum of Peeling Skin Syndrome-Type B Patients Suggests an Over-desquamation of Corneocytes
41. Both Th1 and Th2 chemokines are elevated in sera of patients with autoimmune blistering diseases
42. Serum levels of CCL17/TARC in various skin diseases
43. Quantification of Eight Tissue Kallikreins in the Stratum Corneum and Sweat
44. Elevated Serum BAFF Levels in Patients With Systemic Sclerosis: Enhanced BAFF Signaling in Systemic Sclerosis B Lymphocytes
45. Clinical significance of serum levels of soluble intercellular adhesion molecule-1 and soluble L-selectin in malignant melanoma
46. Abnormal Natural Killer Cell Function in Systemic Sclerosis: Altered Cytokine Production and Defective Killing Activity
47. Anti-DNA topoisomerase II α autoantibodies in Japanese patients with systemic sclerosis
48. Serum Pulmonary and Activation-Regulated Chemokine/CCL18 Levels in Patients With Systemic Sclerosis: A Sensitive Indicator of Active Pulmonary Fibrosis
49. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis☆
50. Implications of Popliteal Lymph Node Detected by Sentinel Lymph Node Biopsy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.